Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I inhaled isoniazid nebulization study in patients with tuberculosis
NL-OMON58619Phase 1Completed
- Sponsor
- University Medical Center Groningen
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of isoniazid in Tuberculosis (TB), sponsored by University Medical Center Groningen. Started Mar 2026; status: completed.
02
Drugs
isoniazid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NL-OMON58619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58619.